Skip To Main Content
Mayte Suárez-Fariñas on Muck Rack

Mayte Suárez-Fariñas

As seen in: Color Research & Application, Nature, PLOS ONE, Cell Press, Canadian Journal of Infectious Diseases & Medical Microbiology, Annals of Internal Medicine, Dove Medical Press, JACC (Journal of the American College of Cardiology), The Journal of Allergy & Clinical Immunology, Gastroenterology and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mayte

Contact Mayte, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Persistence of mucosal CAR-T cells and inflammatory remodeling in enterocolitis associated with BCMA CAR-T cell therapy

|
By Nikhit Kethidi, Saumya Pothukuchi, Adolfo López Alemán, Daniel Charytonowicz, Christina G. Kuhn, Thomas Wong, Jennifer D. Claytor, Pablo Canales-Herrerias, Samane Khoshbakht, Akanksha Acharya, Michael Tankelevich, Divya Jha, Matthias Ceulemans, Alexandra E. Livanos, Catherine Le Berre, Zachary M. Avigan, Luise Fischer, Jacqueline E. Birkness-Gartman, Joanna Melia, Yimei Jin, Isha Parikh, Meenakshi Mehrotra, Shriya Desai, Sidorela Reci, Kedwin Ventura, Rudra Prasad Dutta, Benjamin Gordon, Rachel Brody Verified, Charlotte Cunningham-Rundles, Zhihong Chen, Seunghee Kim-schulze, Parambir S Dulai, Shruti Naik, Jane Houldsworth, Maximilian Merz, Randy S. Longman, Ivan Zanoni, Jeremiah Faith, Jean-Frédéric Colombel, Britta Siegmund, Raja Atreya, Markus F. Neurath, Shambavi Richard, Sundar Jagannath, Jerome Martin, Eric Meffre, Mayte Suárez-Fariñas, David Muniz Pedrogo, Alexandros D. Polydorides, Samir Parekh, Saurabh Mehandru, Erika Patel
| Nature Verified
Abstract B cell-targeted therapies are expanding across oncologic and autoimmune indications, yet their consequences for mucosal immunity remain incompletely examined. Here we define the pathophysiology of ciltacabtagene autoleucel chimeric antigen receptor (CAR)-T cell-induced enterocolitis (EC) (CAR-TEC)—a severe complication of B cell maturation antigen-targeted CAR-T cell therapy in multiple myeloma.
Open in Who Shared Issue with article?

Sa1531 WEARABLE-DERIVED PHYSIOLOGIC SIGNALS DIFFERENTIATE INFLAMMATION FROM REMISSION AFTER BIOLOGIC INITIATION IN INFLAMMATORY BOWEL DISEASE

|
By Robert P. Hirten, Andrew Delgado, Mayte Suárez-Fariñas, Matteo Danieletto, Tim Hewitt, Dylan Schorr, Drew Helmus, Rana Z. Rehman, Ehsanul H. Nirjhar, Meenakshi Chatterjee, Nikolay V. Manyakov, Yanran Huo, Saiyam Jain, Tiffany Lontoc, Kevin Wilby, Bruce E. Sa
| Gastrointestinal Endoscopy Verified
Cookie Preference Center We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.
Open in Who Shared View Duplicates (465) Issue with article?

Individualized treatment effects of CPAP on secondary cardiovascular outcomes in non-sleepy obstructive sleep apnea patients

|
By Oren Cohen, Zainab Al-Taie, Vaishnavi Kundel, Samira Khan, Kavya Devarakonda, Vi D. Le, Philip Robson, Craig Anderson, Mathias Baumert, Kelly A. Loffler, R. Doug McEvoy, Mayte Suárez-Fariñas, Neomi Shah
| Nature Verified
Abstract Continuous positive airway pressure (CPAP) remains the cornerstone of therapy for obstructive sleep apnea, yet its impact on preventing cardiovascular disease remains uncertain. Despite widespread clinical use, randomized controlled trials have not shown cardiovascular benefits with CPAP. Emerging evidence suggests that obstructive sleep apnea is a heterogeneous disease, and a uniform approach to treatment may obscure potential benefits or harm for individuals.
Open in Who Shared Issue with article?
See all 22 licensed articles (23 Total)